All Infection Prevention & Control articles – Page 11
-
NewsPartners launch development of a portable rapid diagnostic system for Ebola virus disease
Professor Yasutoshi Kido of the Graduate School of Medicine, Osaka Metropolitan University (OMU), in collaboration with K.K. DNAFORM and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo, is developing a portable rapid diagnostic system for Ebola virus disease (EVD) caused by Bundibugyo virus (BDBV). ...
-
NewsDrug-resistant gonorrhea on the rise in Europe, ECDC warns
An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhea infection.
-
NewsConnection between forests and rivers strengthens amphibians’ microbiome and protects them against a lethal fungus
A study indicates that a frog’s resistance to a fungus that has decimated hundreds of amphibian species worldwide is due not only to its genes, but also to the beneficial bacteria living on its skin and to the organization of its surrounding landscape.
-
NewsHow did the COVID-19 pandemic shift seasonal surges of other respiratory diseases?
A new analysis explores what underlies shifts in the timing of seasonal surges of respiratory diseases, as well as shifts in surges of heart-related deaths, that occurred after the COVID-19 pandemic began.
-
NewsAt-home, lab-quality HIV tests awarded $1.3 million for development
A new two-year, $1.3 million award will help researchers advance a proof-of-concept work toward commercialization of at-home HIV tests sensitive enough for early diagnosis comparable to—or exceeding—lab standards.
-
NewsResearch team receives $10 million NIH grant to study how animals fight infection
Researchers have built a collection of living cells from over 100 animal species to explore innate immune diversity. They have received a 5-year, $10 million grant to utilize this ‘cellular zoo’ to determine how diverse animals recognize and fight virus infections.
-
NewsMystery of why some toads survive deadly fungus revealed
The mystery of why some populations of amphibians recover following outbreaks of a deadly fungus has been solved in a new study. Researchers looked at peptides that the toads secreted from their skin – a key part of their immune defence.
-
NewsFirst-of-its-kind computer model of bacterial biofilms could support antibiotic resistance research
Faster and more effective ways to treat Pseudomonas aeruginosa could be on the cards thanks to a first-of-its-kind 3D computer model which shows how the bacterium grows and reshapes its protective layer and spreads to new surfaces.
-
NewsClinical trial aims to break the cycle of recurrent urinary tract infections with bacteria’s natural enemies
Researchers’ data-driven microbiological and phage therapy approaches may help move phage therapy beyond case-by-case experimental use toward a strategy that is predictable, measurable and clinically interpretable.
-
NewsPlant-based wound dressing fights infection before it takes hold
A new dressing made from plant-based materials can deliver antibiotics directly to wounds during critical early stages of infection, according to researchers. The study is the first to use this family of sustainable furan-based polymers for infection-fighting wound dressings.
-
NewsThe family tree of viruses just grew – and it paves the way for a new approach to agricultural research
Researchers have discovered that a group of viruses known to infect an agriculturally important plant pathogen has remained genetically stable for an astonishing four decades. The work also led to the classification and naming of the group of phages.
-
NewsWhen a lip ulcer isn’t what it seems: Rare case of syphilis mistaken for mouth injury
Any lip ulcer that is painless, firm, and persists beyond two to three weeks should prompt syphilis testing, even if the presentation does not fit the typical genital picture, warn scientists presenting an unusual case study.
-
NewsNew clues raise hopes for better treatment of RSV in babies
Future therapies for respiratory syncytial virus must target both the virus and its immune response to ensure babies get the best possible outcomes, finds a new study that developed a lab model of baby lungs to show why RSV makes infants so much sicker than adults.
-
NewsFirst clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis
Scientists have published the results of a phase IIa pilot clinical trial assessing ibuprofen as a host-directed therapy in patients with pre-extensively drug-resistant tuberculosis (pre-XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB).
-
NewsHelpful microbes could battle pathogens in our hospitals and schools - with the help of AI to make it work
Helpful microbes that combat harmful pathogens could be the answer to rising antimicrobial resistance, particularly within built environments such as hospitals, homes and schools, says a new review.
-
NewsNew antiseptic capable of eliminating 99.9% of Candida parapsilosis cells
A 0.5% alcohol-based chlorhexidine antiseptic, combined with the natural organic compounds eugenol and menthol, can eliminate 99.9% of Candida parapsilosis cells. This fungus is one of the leading causes of infections in hospital settings.
-
NewsTwo companion papers explain immune ‘exhaustion’ - and how we might prevent it
Chronic and viral infections can literally exhaust certain key cells in the immune system from a constant barrage of attacks. But a new pair of papers has now pointed a way to understand how this exhaustion happens at a molecular level.
-
NewsInternational study maps high risk hotspots of Noma disease in Nigeria
A collaborative international research team has now produced the most detailed mapping of noma incidence risk in Nigeria, uncovering previously unrecognised high-risk areas and providing an important new tool to support prevention and early detection efforts.
-
NewsBrazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment
Following a licensing agreement signed between the Serum Institute of India (SII) and DNDi, a Phase III clinical trial is expected to begin early next year, with the aim of developing a safe, effective, and globally accessible therapeutic for dengue.
-
NewsChikungunya fever: Etiology, pathogenesis, and management, with evidence-based application of traditional Chinese medicine
Traditional Chinese medicine (TCM) offers complementary strategies for acute symptoms and chronic polyarthralgia in Chikungunya infection. A review synthesizes current knowledge on etiology, pathogenesis, clinical features, and management.